Latest Breaking News On - உச்சநிலை சிகிச்சை - Page 1 : vimarsana.com

After Repare IPO success, Amplitude goes all in on Canadian life sciences sector with CA$200M fund

After Repare IPO success, Amplitude goes all in on Canadian life sciences sector with CA$200M fund
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

United statesAl iskandariyahBritish columbiaConley jonesDion madsenGiiant pharmaAlberta enterprise corporationLife sciences fundRoyal bankAmplitude venture capitalRepare therapeuticsAlexandria venture investmentsDeep genomicsNotch therapeuticsSciences fundAlexandria venture investment conley jones

UBC-grown biotech companies lead global pandemic efforts

Millions of Canadians have received the Pfizer-BioNTech COVID-19 vaccine, but what many may not realize is that a key component of the injection was.

British columbiaPeter zandstraDermot kelleherEli lillyCarl hansenHealth drPieter cullisPrecision nanosystemsNotch therapeuticsPresident healthBritish columbiansUniversity of british columbiaFederal governmentGlobal healthHeart diseaseபிரிட்டிஷ் கொலம்பியா

Montreal s Ventus Therapeutics raises $100-million to pursue Holy Grail disease targets

Montreal’s Ventus Therapeutics raises $100-million to pursue ‘Holy Grail’ disease targets Bookmark Please log in to listen to this story. Also available in French and Mandarin. Log In Create Free Account Getting audio file . This translation has been automatically generated and has not been verified for accuracy. Full Disclaimer Marc Bruxelle/iStock Editorial / Getty Images Ventus Therapeutics Inc. is the latest in a string of Canadian biotechnology startups to land significant funds from top North American investors. The two-year-old Montreal company has raised US$100-million led by Boston-based RA Capital Management and backed by U.S. funds BVF Partners, Casdin Capital and Cormorant Asset Management, plus Fonds de solidarité FTQ, Canada’s leading institutional investor in the sector.

United statesNova scotiaBritish columbiaSan franciscoMarc bruxelleJerel davisMarcelo bigalVertex pharmaceuticals incVentus therapeutics incMerck coAlphabet incPoint biopharma incTeva pharmaceuticals industries ltdBoehringer ingelheim international gmbStock editorialNorth american

Lifesciences BC s 6th Annual ACCESS TO INNOVATION Conference Will Generate Important Conversation Between R&D, Academia, Industry and Government

Press release content from Business Wire. The AP news staff was not involved in its creation. Lifesciences BC’s 6th Annual ACCESS TO INNOVATION Conference Will Generate Important Conversation Between R&D, Academia, Industry and Government February 22, 2021 GMT A compelling and critical conversation will unfold over a two-day period at February 24 – 25, 2021, will host thought leaders from health research & innovation, academia, industry, and government, as well as key individuals in the life science sector from across the country and abroad. The conversation is about therapeutic innovation, improving health and patient care, while supporting the post COVID-19 economic recovery of British Columbia.

United statesUnited kingdomBritish columbiaStephanie willerthCarl hansenSusan ogilvieJames taylorMark caulfieldKamran shaikhGreg davignonAbcellera biologicsAllan mirandaJohn horganRavi kahlonPeter zandstraWendy hurlburt

Notch Therapeutics raises $85M for cancer treatments and plans to open Seattle location

Notch Therapeutics raises $85M for cancer treatments and plans to open Seattle location
geekwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from geekwire.com Daily Mail and Mail on Sunday newspapers.

Peter zandstraUniversity of torontoNotch therapeuticsChief scientific officer peterNotch photosபல்கலைக்கழகம் ஆஃப் டொராண்டோஉச்சநிலை சிகிச்சை